Evidence map›Paper›PMID 28321191›Full record

ArticleFrontiers in pharmacology2017

Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury.

Francesca Guida, Serena Boccella, Monica Iannotta, Danilo De Gregorio, Catia Giordano, Carmela Belardo, Rosaria Romano, Enza Palazzo, Maria A Scafuro, Nicola Serra and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Palmitoylethanolamide: A Natural Compound for Health Management.International journal of molecular sciences · 2021
    Review
  15. Review
  16. Article
  17. New pathway ameliorating ulcerative colitis: focus onTherapeutic advances in gastroenterology · 2021
    Article
  18. Article
  19. Article
  20. Aberrant ER Stress Induced Neuronal-IFNβ Elicits White Matter Injury Due to Microglial Activation and T-Cell Infiltration after TBI.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Francesca GuidaDepartment of Experimental Medicine, Section of Pharmacology "L. Donatelli", Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN)Naples, Italy; Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle RicerchePozzuoli, Italy.
Serena BoccellaDepartment of Experimental Medicine, Section of Pharmacology "L. Donatelli", Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN) Naples, Italy.
Monica IannottaDepartment of Experimental Medicine, Section of Pharmacology "L. Donatelli", Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN) Naples, Italy.
Danilo De GregorioDepartment of Experimental Medicine, Section of Pharmacology "L. Donatelli", Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN) Naples, Italy.
Catia GiordanoDepartment of Experimental Medicine, Section of Pharmacology "L. Donatelli", Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN) Naples, Italy.
Carmela BelardoDepartment of Experimental Medicine, Section of Pharmacology "L. Donatelli", Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN) Naples, Italy.
Rosaria RomanoDepartment of Experimental Medicine, Section of Pharmacology "L. Donatelli", Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN) Naples, Italy.
Enza PalazzoDepartment of Experimental Medicine, Section of Pharmacology "L. Donatelli", Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN) Naples, Italy.
Maria A ScafuroDepartment of Anesthesiology, Surgery and Emergency, Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN) Naples, Italy.
Nicola SerraDepartment of Radiology, Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN) Naples, Italy.
Vito de NovellisDepartment of Experimental Medicine, Section of Pharmacology "L. Donatelli", Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN) Naples, Italy.
Francesco RossiDepartment of Experimental Medicine, Section of Pharmacology "L. Donatelli", Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN) Naples, Italy.
Sabatino MaioneDepartment of Experimental Medicine, Section of Pharmacology "L. Donatelli", Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN)Naples, Italy; Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle RicerchePozzuoli, Italy.
Livio LuongoDepartment of Experimental Medicine, Section of Pharmacology "L. Donatelli", Università degli Studi della Campania "Luigi Vanvitelli" (Ex SUN)Naples, Italy; Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle RicerchePozzuoli, Italy; Young Against Pain (YAP) Italian Group, NaplesItaly.
University of Campania "Luigi Vanvitelli" · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traumatic brain injury (TBI) represents a major public health problem, which is associated with neurological dysfunction. In severe or moderate cases of TBI, in addition to its high mortality rate, subjects may encounter diverse behavioral dysfunctions. Previous reports suggest that an association between TBI and chronic pain syndromes tends to be more common in patients with mild forms of brain injury. Despite causing minimal brain damage, mild TBI (mTBI) often leads to persistent psychologically debilitating symptoms, which can include anxiety, various forms of memory and learning deficits, and depression. At present, no effective treatment options are available for these symptoms, and little is known about the complex cellular activity affecting neuronal activity that occurs in response to TBI during its late phase. Here, we used a mouse model to investigate the effect of Palmitoylethanolamide (PEA) on both the sensorial and neuropsychiatric dysfunctions associated with mTBI through behavioral, electrophysiological, and biomolecular approaches. Fourteen-day mTBI mice developed anxious, aggressive, and reckless behavior, whilst depressive-like behavior and impaired social interactions were observed from the 60th day onward. Altered behavior was associated with changes in interleukin 1 beta (IL-1β) expression levels and neuronal firing activity in the medial prefrontal cortex. Compared with vehicle, PEA restored the behavioral phenotype and partially normalized the biochemical and functional changes occurring at the supraspinal level. In conclusion, our findings reveal some of the supraspinal modifications responsible for the behavioral alterations associated with mTBI and suggest PEA as a pharmacological tool to ameliorate neurological dysfunction induced by the trauma.

Indexed as

aggressive behaviorin vivo electrophysiologymedial prefrontal cortexmice depressionPalmitoylethanolamidetraumatic brain injury

Identifiers

PMID28321191
PMCPMC5337754
OpenAlexW2600746387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.